SMARCB1 and carcinoma: NET G3, on the other hand, was suggested as diagnosis in 10 NETs G2, 5 NECs, 7 MiNENs, and various other carcinomas including medullary thyroid carcinoma, adenocarcinoma, squamous cell carcinoma, acinar cell carcinoma, and SMARCB1-deficient neoplasm (data not shown).